Clearmind Announces Positive Safety Findings for CMND 100, Demonstrating Consistent Tolerability Throughout Full Dose Escalation in Part A of its FDA-Regulated Clinical Trial
Go back to Clearmind Announces Positive Safety Findings for CMND 100, Demonstrating Consistent Tolerability Throughout Full Dose Escalation in Part A of its FDA-Regulated Clinical Trial| (NASDAQ: CMND) | Delayed: 0.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.79 | 52 Week High | $ | |||
| Open | $0.79 | 52 Week Low | $ | |||
| Day High | $0.79 | P/E | N/A | |||
| Day Low | $0.79 | EPS | $ | |||
| Volume | 5,520 | |||||
